BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biotech Holdings Ltd. (BIOHF) Sales Of Sucanon Show Quarterly Growth


1/16/2007 10:13:13 AM

VANCOUVER, Jan. 16 /PRNewswire-FirstCall/ - Biotech Holdings reports that sales for the quarter ended December 31, 2006 exceeded the combined sales of the first two quarters, ended September 30, 2006, by $55,692 or 73%. The sales during the quarter ended December 31/06, at $127,194, exceeds sales of $99,137 generated during the quarter ended December 31, 2005, and is the second-largest quarterly sales total recorded to date. The Company's interim financial statements, complete with Management Discussion and Analysis for the third quarter, ended December 31, 2006, will be issued in February, 2007, with filing to www.sedar.com, where all prior financial statements together with Management Discussion and Analysis are available.

In addition to the year-over-year sales increase, sales during the December 31/06 quarter itself increased each month, suggesting a trend of sales growth following the Company's resumption of advertising support for the product and the Company's managers taking over the marketing of Sucanon in Mexico in September, 2006.

This release has been approved by the Board of Directors of Biotech Holdings.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. Robert B. Rieveley, Pres. On behalf of the Board of Directors

Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed.

CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free), 8 a.m. to 4 p.m. Pacific time; for background information on Biotech Holdings, or to receive news updates, see www.biotechltd.com

Biotech Holdings Ltd.

CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free), 8a.m. to 4 p.m. Pacific time; for background information on BiotechHoldings, or to receive news updates, see www.biotechltd.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES